MedTrace Logo

Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder

NCT04549051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-05-29

Study results available
· View outcomes & findings →

Summary

Percutaneous Interruption of the Coracohumeral Ligament for the treatment of Frozen Shoulder.

Conditions

  • Adhesive Capsulitis

Interventions

DEVICE

Tenex

Local anesthetic plus Tenex into the coracohumeral ligament for adhesive capsulitis

DRUG

Local anesthetic

Only local anesthetic into the coracohumeral ligament for adhesive capsulitis

Sponsors & Collaborators

  • Albert Einstein College of Medicine

    lead OTHER

Principal Investigators

  • Sayed Wahezi, MD · Montefiore Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-17
Primary Completion
2022-03-16
Completion
2023-01-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04549051 on ClinicalTrials.gov